23ck5qw4f3otp3jh1fyzqasx
23ck5qw4f3otp3jh1fyzqasx
23ck5qw4f3otp3jh1fyzqasx
Test Report
Note
1. INR is the parameter of choice in monitoring adequacy of oral anticoagulant therapy. Appropriate
therapeutic range varies with the disease and treatment intensity
2. Prolonged INR suggests potential bleeding disorder / bleeding complications
3. Results should be clinically correlated
4. Test conducted on Citrated plasma
Comments
Prothrombin time measures the extrinsic coagulation pathway which consists of activated Factor VII (VIIa),
Tissue factor and Proteins of the common pathway (Factors X, V, II & Fibrinogen). This assay is used to
control long term oral anticoagulant therapy, evaluation of liver function & to evaluate coagulation disorders
specially factors involved in the extrinsic pathway like Factors V, VII, X, Prothrombin & Fibrinogen.
*186105358*
Page 1 of 8
.
Test Report
Note
1. In an asymptomatic patient, Non alcoholic fatty liver disease (NAFLD) is the most common cause of
increased AST, ALT levels. NAFLD is considered as hepatic manifestation of metabolic syndrome.
2. In most type of liver disease, ALT activity is higher than that of AST; exception may be seen in Alcoholic
Hepatitis, Hepatic Cirrhosis, and Liver neoplasia. In a patient with Chronic liver disease, AST:ALT
ratio>1 is highly suggestive of advanced liver fibrosis.
3. In known cases of Chronic Liver disease due to Viral Hepatitis B & C, Alcoholic liver disease or NAFLD,
Enhanced liver fibrosis (ELF) test may be used to evaluate liver fibrosis.
4. In a patient with Chronic Liver disease, AFP and Des-gamma carboxyprothrombin (DCP)/PIVKA II can
be used to assess risk for development of Hepatocellular Carcinoma.
*186105358* Page 2 of 8
.
Test Report
Note
1. Estimated GFR (eGFR) calculated using the 2021 CKD-EPI creatinine equation and GFR Category
reported as per KDIGO guideline 2012.
2. eGFR category G1 or G2 does not fulfil the criteria for CKD, in the absence of evidence of kidney
damage
3. The BUN-to-creatinine ratio is used to differentiate prerenal and postrenal azotemia from renal
azotemia. Because of considerable variability, it should be used only as a rough guide. Normally, the
BUN/creatinine ratio is about 10:1
*186105358* Page 3 of 8
.
Test Report
*186105358* Page 4 of 8
.
Test Report
Note
1. As per the recommendation of International council for Standardization in Hematology, the differential
leucocyte counts are additionally being reported as absolute numbers of each cell in per unit volume of
blood
2. Test conducted on EDTA whole blood
*186105358* Page 5 of 8
.
Test Report
Gross Examination
Microscopy
*186105358*
Page 6 of 8
.
Test Report
Result Rechecked
Dr Ajay Gupta Dr.Anirudh Bharat Kumar Gupta Dr Anjalika Goyal Dr Himangshu Mazumdar
MD, Pathology MD, Microbiology MD,Biochemistry MD, Biochemistry
Technical Director - Hematology & Senior Consultant Microbiologist Consultant Biochemist Sr. Consultant Biochemist
Immunology NRL - Dr Lal PathLabs Ltd NRL - Dr Lal PathLabs Ltd NRL - Dr Lal PathLabs Ltd
NRL - Dr Lal PathLabs Ltd
Dr Sunanda
MD, Pathology
Sr. Consultant Pathologist -
Hematology & Immunology
NRL - Dr Lal PathLabs Ltd
*186105358*
Page 7 of 8
.
Test Report
*186105358*
Page 8 of 8